BAFF / APRIL Inhibitors Homing in on IgAN
Today we discuss the group of BAFF/APRIL inhibitors, specifically the three TACI mAb constructs that are currently in development. They were tested in a broad gamut of B-cell indications but failed to show efficacy in many. So far, consistent clinical Continue reading BAFF / APRIL Inhibitors Homing in on IgAN